Author Interview - Professor Andrew Cope, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they discuss his recent pape...
5 Maalis 24min
Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Taylor et al. where authors report the...
27 Helmi 8min
Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘classification of patients into distinct PsA phenotype...
13 Helmi 20min
Author Interview: Professor Matthew Brown, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as they discuss his recent paper ‘Low uveitis rates i...
3 Helmi 18min
Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al. that evaluated TOF effic...
29 Tammi 9min
Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor Reike Alten will be reviewing two papers. The firs...
18 Joulu 202522min
Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional s...
11 Joulu 202513min
Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secu...
4 Joulu 202520min
